Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119045) titled 'A Clinical Study of PUMCH-E111 Administered via Intravitreal Injection in Subjects with RLBP1-related Inherited Retinal Dystrophy' on Feb. 14.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking Union Medical College Hospital
Condition:
inherited retinal dystrophy related to RLBP1 gene variations.
Intervention:
Low-dose group:Intravitreal injection of PUMCH-E111
Recruitment Status: Not Recruiting
Phase: 1-2
Date of First Enrollment: 2026-02-24
Target Sample Size: Low-dose group:4;High-dose group:4;
Countries of Recruitment:
China
To know more, visit https://www.chict...